Inovio shares surge 186% after FDA approves rare-disease treatment
Inovio Pharmaceuticals shares surged 186% after the FDA approved a treatment for a rare respiratory condition.
Related stories
UK to Extend Settlement Wait for Some Migrants to 10 Years
The UK will make some migrants wait 10 years to settle while easing rules for carers.
L impact | REGULATION | Nov 02, 2026, 03:48 PM UTC
Chile’s Public Debt Rises Sharply Through September, Nearing 45% of GDP Prudential Limit
Chile’s public debt recorded strong growth through September, leaving the government close to the prudential limit of 45% of GDP.
H impact | REGULATION | Nov 02, 2026, 03:42 PM UTC
India Regulator Backs Scrapping Capital Gains Tax for Foreigners
An Indian regulator backs scrapping the long-term capital gains tax for foreign investors, according to sources.
L impact | REGULATION | Nov 02, 2026, 03:40 PM UTC
Tax Department Searches Muthoot Finance Office on Oct. 29-30
Muthoot Finance says the tax department conducted a search and seizure at its registered office on Oct. 29-30, 2026.
M impact | REGULATION | Nov 02, 2026, 03:30 PM UTC
Indofood Agri Unit Cooperates With Singapore Authorities in Haze Probe
Indofood says its agriculture unit is cooperating with Singapore authorities in a haze probe.
L impact | REGULATION | Nov 02, 2026, 03:25 PM UTC
China Central Bank Intervenes Again to Stem Stock Market Declines
China's central bank intervened again on Monday to stem declines in the country's stock market. The iShares MSCI China A ETF, which tracks domestically listed companies, is down 14
M impact | REGULATION | Nov 02, 2026, 03:07 PM UTC